voretigene neparvovec (Luxturna) Report issue

Gene therapy Orphan Drug FDA Approved FDA Breakthrough Therapy FDA

Active Ingredient History

  • Now
Voretigene neparvovec, sold under the brand name Luxturna, is a gene therapy medication for the treatment of Leber congenital amaurosis.   Wikipedia

More Chemistry


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue